Favipiravir as a potent inhibitor of Newcastle disease virus: <i>in ovo</i> efficacy, dose-dependent toxicity, and molecular insights into RNA polymerase inhibition. [PDF]
Soomro NA +4 more
europepmc +1 more source
Estimating Standard-Dose and High-Dose Fluzone Vaccine Efficacies for Influenza A Based on Hemagglutination Inhibition Titers. [PDF]
Hammerton SM +5 more
europepmc +1 more source
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel. [PDF]
Mishina M +26 more
europepmc +1 more source
Evaluation of humoral immune response and milk antibody transfer in calves and lactating cows vaccinated with inactivated H5 avian influenza vaccine. [PDF]
Abousenna MS, Shafik NG, Abotaleb MM.
europepmc +1 more source
An intranasal adjuvanted, recombinant influenza A/H5 vaccine primes against diverse H5N1 clades: a phase I trial. [PDF]
Deming ME +20 more
europepmc +1 more source
Serologic Status of Newcastle Disease in Native Chickens by Hemagglutination Inhibition Test
Arlyn Jave B. Adlawon +2 more
openalex +1 more source
Unveiling Indirect ELISA Test against Nucleoprotein of H9N2 Comparing With Hemagglutination Inhibition Test. [PDF]
Madani R, Hezarosi M, Golchinfar F.
europepmc +1 more source
Enhanced and Prolonged Immunogenicity in Mice of Thermally Stabilized Fatty Acid-Conjugated Vaccine Antigen. [PDF]
Kim BM +5 more
europepmc +1 more source
Passive Hemagglutination-Inhibition Test for Typing Foot-and-Mouth Disease Virus
R. E. Warrington, Y Kawakami
openalex +1 more source

